Literature DB >> 22205609

γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

Xiaoping Qi1, Jun Cai, Qing Ruan, Li Liu, Sanford L Boye, Zhijuan Chen, William W Hauswirth, Renee C Ryals, Lynn Shaw, Sergio Caballero, Maria B Grant, Michael E Boulton.   

Abstract

PURPOSE: This study aimed to determine whether upregulation of γ-secretase could inhibit laser-induced choroidal neovascularization (CNV) and if this was associated with a reduction in both oxidative stress and proinflammatory cytokines.
METHODS: γ-Secretase, or its catalytic subunit presenilin 1 (PS1), were upregulated by exposure to either pigment epithelial derived factor (PEDF) or an AAV2 vector containing a PS1 gene driven by a vascular endothelial-cadherin promoter. Retinal endothelial cells were infected with AAV2 or exposed to PEDF in the presence or absence of VEGF and in vitro angiogenesis determined. Mouse eyes either received intravitreal injection of PEDF, DAPT (a γ-secretase inhibitor) or PEDF + DAPT at the time of laser injury, or AAV2 infection 3 weeks before receiving laser burns. Lesion volume was determined 14 days post laser injury. Superoxide generation, antioxidant activity and the production of proinflammatory mediators were assessed. Knockdown of γ-secretase was achieved using siRNA.
RESULTS: γ-Secretase upregulation and PS1 overexpression suppressed VEGF-induced in vitro angiogenesis and in vivo laser-induced CNV. This was associated with a reduction in the expression of VEGF and angiogenin 1 together with reduced superoxide anion generation and an increase in MnSOD compared with untreated CNV eyes. PS1 overexpression reduced proinflammatory factors and microglial activation in eyes with CNV compared with control. siRNA inhibition of γ-secretase resulted in increased angiogenesis.
CONCLUSIONS: γ-Secretase, and in particular PS1 alone, are potent regulators of angiogenesis and this is due in part to stabilizing endogenous superoxide generation and reducing proinflammatory cytokine expression during CNV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22205609      PMCID: PMC3317409          DOI: 10.1167/iovs.11-8728

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  72 in total

1.  Production and purification of recombinant adeno-associated virus.

Authors:  W W Hauswirth; A S Lewin; S Zolotukhin; N Muzyczka
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells.

Authors:  Akiko Oda; Akira Tamaoka; Wataru Araki
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

3.  Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.

Authors:  Jun Cai; Wen G Jiang; Maria B Grant; Mike Boulton
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

4.  Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.

Authors:  Ji Jin; Kevin K Zhou; Kyoungmin Park; Yang Hu; Xun Xu; Zhi Zheng; Puneet Tyagi; Uday B Kompella; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-05       Impact factor: 4.799

Review 5.  The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Authors:  S Beatty; H Koh; M Phil; D Henson; M Boulton
Journal:  Surv Ophthalmol       Date:  2000 Sep-Oct       Impact factor: 6.048

6.  Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice.

Authors:  Qiuhong Li; Astra Dinculescu; Zhiying Shan; Rehae Miller; Jijing Pang; Alfred S Lewin; Mohan K Raizada; William W Hauswirth
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 7.  Current concepts in the pathogenesis of age-related macular degeneration.

Authors:  Marco A Zarbin
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

Review 9.  Vascular endothelial growth factor and its relationship to inflammatory mediators.

Authors:  Laura S Angelo; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

10.  Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion.

Authors:  Mattias Kalén; Tommi Heikura; Henna Karvinen; Anja Nitzsche; Holger Weber; Norbert Esser; Seppo Ylä-Herttuala; Mats Hellström
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

View more
  10 in total

1.  A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Authors:  Rania S Sulaiman; Judith Quigley; Xiaoping Qi; Michael N O'Hare; Maria B Grant; Michael E Boulton; Timothy W Corson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-10       Impact factor: 2.671

2.  Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.

Authors:  Jingjing Zhang; Gongqiang Yuan; Muchen Dong; Ting Zhang; Gao Hua; Qingjun Zhou; Weiyun Shi
Journal:  Histochem Cell Biol       Date:  2016-09-07       Impact factor: 4.304

3.  Supplemental nitrite increases choroidal neovascularization in mice.

Authors:  Xiaoping Qi; Karina Ricart; Khandaker A Ahmed; Rakesh P Patel; Michael E Boulton
Journal:  Nitric Oxide       Date:  2021-09-16       Impact factor: 4.427

4.  Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization.

Authors:  Li Liu; Xiaoping Qi; Zhijuan Chen; Lynn Shaw; Jun Cai; Layton H Smith; Maria B Grant; Michael E Boulton
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

5.  Occludin S490 Phosphorylation Regulates Vascular Endothelial Growth Factor-Induced Retinal Neovascularization.

Authors:  Xuwen Liu; Alyssa Dreffs; Monica Díaz-Coránguez; E Aaron Runkle; Thomas W Gardner; Vince A Chiodo; William W Hauswirth; David A Antonetti
Journal:  Am J Pathol       Date:  2016-07-14       Impact factor: 4.307

6.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

7.  Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development.

Authors:  Qing Ruan; Lei Xi; Sanford L Boye; Song Han; Zhi J Chen; William W Hauswirth; Alfed S Lewin; Michael E Boulton; Brian K Law; Wen G Jiang; Huabei Jiang; Jun Cai
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

8.  Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications.

Authors:  Jiaxin Liu; Xueyan Zhang; Ge Li; Fei Xu; Shuang Li; Lesheng Teng; Youxin Li; Fengying Sun
Journal:  Int J Nanomedicine       Date:  2019-11-08

9.  RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model.

Authors:  Chaoyang Zhang; Shiyue Qin; Hai Xie; Qinghua Qiu; Haiyan Wang; Jingting Zhang; Dawei Luo; Jingfa Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

10.  Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization.

Authors:  Danielle McAnally; Khandaker Siddiquee; Ahmed Gomaa; Andras Szabo; Stefan Vasile; Patrick R Maloney; Daniela B Divlianska; Satyamaheshwar Peddibhotla; Camilo J Morfa; Paul Hershberger; Rebecca Falter; Robert Williamson; David B Terry; Rafal Farjo; Anthony B Pinkerton; Xiaping Qi; Judith Quigley; Michael E Boulton; Maria B Grant; Layton H Smith
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.